mGlu5-dependent modulation of anxiety during early withdrawal from binge-drinking in adult and adolescent male mice

被引:28
作者
Lee, Kaziya M. [1 ]
Coelho, Michal A. [1 ]
Class, MacKayla A. [1 ,2 ,3 ]
Szumlinski, Karen K. [1 ,2 ,3 ]
机构
[1] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA
[2] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA
[3] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA
关键词
Binge-drinking; Adolescence; Group 1 metabotropic glutamate receptors; Anxiety; Alcoholism; METABOTROPIC GLUTAMATE RECEPTORS; NUCLEUS-ACCUMBENS SHELL; ALCOHOL-DRINKING; C57BL/6J MICE; ETHANOL-CONSUMPTION; ALLOSTERIC MODULATORS; MGLUR5; ANTAGONISTS; SEEKING BEHAVIOR; SCREENING-TEST; IN-VIVO;
D O I
10.1016/j.drugalcdep.2017.10.031
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Binge alcohol-drinking elicits symptoms of negative affect such as anxiety upon cessation, which is a source of negative reinforcement for perpetuating this pattern of alcohol abuse. Binge-induced anxiety during early (24 h) withdrawal is associated with increased expression of metabotropic glutamate receptor 5 (mGlu5) within the nucleus accumbens shell (AcbSh) of adult male mice, but was unchanged in anxiety-resilient adolescents. Herein, we determined the role of mGlu5 signaling in withdrawal-induced anxiety via pharmacological manipulation using the mGlu5 negative allosteric modulator MTEP and the positive allosteric modulator CDPPB. Adult (PND 56) and adolescent (PND 28) male C57BL/6J mice binge-drank for 14 days under 3-bottle-choice procedures for 2 h/day; control animals drank water only. Approximately 24 h following the final alcohol presentation, animals were treated with 30 mg/kg IP MTEP, CDPPB, or vehicle and then tested, thirty minutes later, for behavioral signs of anxiety. Vehicle-treated binge-drinking adults exhibited hyperanxiety in all paradigms, while vehicle treated binge-drinking adolescents did not exhibit withdrawal-induced anxiety. In adults, 30 mg/kg MTEP decreased alcohol-induced anxiety across paradigms, while 3 mg/kg MTEP was anxiolytic in adult water controls. CDPPB was modestly anxiogenic in both alcohol-and water-drinking mice. Adolescent animals showed minimal response to either CDPPB or MTEP, suggesting that anxiety in adolescence may be mGlu5-independent. These results demonstrate a causal role for mGlu5 in withdrawal-induced anxiety in adults and suggest age-related differences in the behavioral pharmacology of the negative reinforcing properties of alcohol.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 67 条
[1]  
[Anonymous], INNOV PHARM TECHNOL
[2]   mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior [J].
Bäckström, P ;
Bachteler, D ;
Koch, S ;
Hyytiä, P ;
Spanagel, R .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (05) :921-928
[3]   KINDLING AS A MODEL FOR ALCOHOL WITHDRAWAL SYNDROMES [J].
BALLENGER, JC ;
POST, RM .
BRITISH JOURNAL OF PSYCHIATRY, 1978, 133 (JUL) :1-14
[4]   REPEATED EPISODES OF ETHANOL WITHDRAWAL POTENTIATE THE SEVERITY OF SUBSEQUENT WITHDRAWAL SEIZURES - AN ANIMAL-MODEL OF ALCOHOL-WITHDRAWAL KINDLING [J].
BECKER, HC ;
HALE, RL .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1993, 17 (01) :94-98
[5]   Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests [J].
Belozertseva, I. V. ;
Kos, T. ;
Popik, P. ;
Danysz, W. ;
Bespalov, A. Y. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (03) :172-179
[6]   Glutamate and anxiety [J].
Bergink, V ;
van Megen, HJGM ;
Westenberg, HGM .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 (03) :175-183
[7]   The mouse light/dark box test [J].
Bourin, M ;
Hascoët, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 463 (1-3) :55-65
[8]   The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine, (MTEP) in rodent models of anxiety [J].
Busse, CS ;
Brodkin, J ;
Tattersall, D ;
Anderson, JJ ;
Warren, N ;
Tehrani, L ;
Bristow, LJ ;
Varney, MA ;
Cosford, NDP .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (11) :1971-1979
[9]  
CARRINGTON CD, 1984, BIOL PSYCHIAT, V19, P525
[10]  
Centers for Disease Control and Prevention, 2014, FACT SHEETS UND DRIN